MAKERSL
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Makers Laboratories Received EAEU RU GMP Certificate For Opthalmic Eye Drops Manufacturing Facility
Oct 4 (Reuters) - Makers Laboratories Ltd MKRS.BO:
RECEIPT OF EAEU RU GMP CERTIFICATE FOR OPTHALMIC EYE DROPS MANUFACTURING FACILITY
Source text for Eikon: ID:nBSE2BDC78
Further company coverage: MKRS.BO
(([email protected];))
Oct 4 (Reuters) - Makers Laboratories Ltd MKRS.BO:
RECEIPT OF EAEU RU GMP CERTIFICATE FOR OPTHALMIC EYE DROPS MANUFACTURING FACILITY
Source text for Eikon: ID:nBSE2BDC78
Further company coverage: MKRS.BO
(([email protected];))
Events:
Rights
Dividend
Dividend
Dividend
Dividend
Dividend
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Makers Laboratories do?
Makers Laboratories Ltd specializes in manufacturing pharmaceutical formulations and drug intermediaries, offering a wide range of products including tablets, capsules, liquids, injectables, drugs intermediates, creams, and ointments.
Who are the competitors of Makers Laboratories?
Makers Laboratories major competitors are Bharat Immunological, Biofil Chem & Pharma, Achyut Healthcare, Murae Organisor, Dipna Pharma., Deccan Health Care, Denis Chem Lab. Market Cap of Makers Laboratories is ₹91 Crs. While the median market cap of its peers are ₹93 Crs.
Is Makers Laboratories financially stable compared to its competitors?
Makers Laboratories seems to be less financially stable compared to its competitors. Altman Z score of Makers Laboratories is 2.34 and is ranked 5 out of its 8 competitors.
Does Makers Laboratories pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Makers Laboratories latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Makers Laboratories allocated its funds?
Companies resources are majorly tied in miscellaneous assets
How strong is Makers Laboratories balance sheet?
Balance sheet of Makers Laboratories is moderately strong.
Is the profitablity of Makers Laboratories improving?
Yes, profit is increasing. The profit of Makers Laboratories is ₹12.9 Crs for TTM, ₹7.49 Crs for Mar 2025 and -₹6.26 Crs for Mar 2024.
Is the debt of Makers Laboratories increasing or decreasing?
The debt of Makers Laboratories is decreasing. Latest debt of Makers Laboratories is ₹2.1 Crs as of Mar-25. This is less than Mar-24 when it was ₹13.24 Crs.
Is Makers Laboratories stock expensive?
Makers Laboratories is not expensive. Latest PE of Makers Laboratories is 10.22, while 3 year average PE is 10.31. Also latest EV/EBITDA of Makers Laboratories is 9.77 while 3yr average is 22.12.
Has the share price of Makers Laboratories grown faster than its competition?
Makers Laboratories has given better returns compared to its competitors. Makers Laboratories has grown at ~17.75% over the last 2yrs while peers have grown at a median rate of -3.42%
Is the promoter bullish about Makers Laboratories?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Makers Laboratories is 61.27% and last quarter promoter holding is 61.27%.
Are mutual funds buying/selling Makers Laboratories?
There is Insufficient data to gauge this.